|
| Status |
Public on Nov 27, 2015 |
| Title |
Sample12_Tumor |
| Sample type |
genomic |
| |
|
| Source name |
lung adenocarcinoma
|
| Organism |
Homo sapiens |
| Characteristics |
gender: Female
tissue: Tumor
Stage: 2
p53 status: Mutated
egfr status: WildType
kras status: WildType
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
The tumor tissue and normal tissue were obtained at surgery and snap frozen in liquid nitrogen and stored at 80°C until DNA isolation. DNA was extracted using Maxwell 16 DNA Purification kit (http://www.promega.com) and the Maxwell 16 instrument after standard procedure.
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridized to Illumina Infinium Human Methylation450 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Description |
Sentrix_ID: 5775278085
Sentrix_Position: R05C01
|
| Data processing |
Touleimat and Tost, Epigenomics 2012
|
| |
|
| Submission date |
Mar 12, 2015 |
| Last update date |
Nov 27, 2015 |
| Contact name |
Thomas Fleischer |
| E-mail(s) |
[email protected]
|
| Organization name |
Oslo University Hospital
|
| Department |
Department of Cancer Genetics, Institute for Cancer Research
|
| Street address |
Ullernchausséen 70
|
| City |
Oslo |
| ZIP/Postal code |
0310 |
| Country |
Norway |
| |
|
| Platform ID |
GPL13534 |
| Series (1) |
| GSE66836 |
Genome-wide DNA methylation signature in lung adenocarcinomas has prognostic impact |
|
